Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paul C. Moser
Observed names:
Moser,
P C Moser,
P Moser,
P. C. Moser,
P. Moser,
P.C. Moser,
PAUL C. MOSER,
Paul C Moser,
Paul Moser
show all 9
Institution:
Bial (Portugal)
Observed institutions:
Bial (Portugal),
Sanofi (France),
Ospedale San Paolo,
Porsolt (France),
Pierre Fabre (France),
Institut de Recherche Pierre Fabre (France),
University of Bath
show all 7
ORCID:
0000-0002-6887-3508
Observed ORCID:
0000-0002-6887-3508
OpenAlex ID:
A5034339136
Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice
2011
·
Vincent Castagné
, Paul Moser
, et al.
·
Current Protocols in Neuroscience
·
776
Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice
2010
·
Vincent Castagné
, Paul Moser
, et al.
·
Current Protocols in Pharmacology
·
522
Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein.
1995
·
P M Moran
, L S Higgins
, et al.
·
Proceedings of the National Academy of Sciences
·
380
The pharmacology of latent inhibition as an animal model of schizophrenia
2000
·
Paul C Moser
, Janice M Hitchcock
, et al.
·
Brain Research Reviews
·
261
An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone
1989
·
P. C. Moser
·
Psychopharmacology
·
200
Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area
1998
·
Eric Charpantier
, Pascal Barnéoud
, et al.
·
Neuroreport
·
177
Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse
2009
·
Vincent Castagné
, Roger D. Porsolt
, et al.
·
European Journal of Pharmacology
·
167
Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies
2000
·
Anne Blondel
, David J. Sanger
, et al.
·
Psychopharmacology
·
146
Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function
1993
·
Michael G. Palfreyman
, Christopher J. Schmidt
, et al.
·
Psychopharmacology
·
134
SL65.0155, A Novel 5-Hydroxytryptamine4 Receptor Partial Agonist with Potent Cognition-Enhancing Properties
2002
·
Paul C. Moser
, Olivier E. Bergis
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
130
Characterization of MDL 73005EF as a 5‐HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8‐OH‐DPAT and diazepam
1990
·
P.C. Moser
, M.D. Tricklebank
, et al.
·
British Journal of Pharmacology
·
118
PDF
Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist
1995
·
P.C. Moser
, P.M. Moran
, et al.
·
Behavioural Brain Research
·
116
Behavioral Indices in Antipsychotic Drug Discovery
2010
·
Roger D. Porsolt
, Paul C. Moser
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
110
Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets
2016
·
Anton Bespalov
, Thomas Steckler
, et al.
·
Nature Reviews Drug Discovery
·
101
PDF
Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies
2011
·
James J. Lynch
, Vincent Castagné
, et al.
·
Journal of Pharmacological and Toxicological Methods
·
98
Quantitative motor assessment in FALS mice: a longitudinal study
1997
·
Pascal Barnéoud
, Jocelyne Lolivier
, et al.
·
Neuroreport
·
79
Pharmacological properties of dolasetron, a potent and selective antagonist at 5‐HT3 receptors
1993
·
Robert C. Miller
, Martin Galvan
, et al.
·
Drug Development Research
·
79
Effects of clozapine on latent inhibition in the rat
1996
·
P. M. Moran
, T. R. Fischer
, et al.
·
Behavioural Pharmacology
·
77
Preclinical Behavioral Models for Predicting Antipsychotic Activity
2009
·
Vincent Castagné
, Paul C. Moser
, et al.
·
Advances in pharmacology
·
73
Amine Uptake Inhibitors: Criteria of Selectivity
1980
·
L. Maître
, P. Moser
, et al.
·
Acta Psychiatrica Scandinavica
·
71
Behavioral Assessment of Antidepressant Activity in Rodents
2008
·
Roger Porsolt
, Vincent Castagné
, et al.
·
Frontiers in neuroscience
·
60
D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats
2008
·
E. Esneault
, V. Castagne
, et al.
·
Neuroscience
·
58
Out of Control? Managing Baseline Variability in Experimental Studies with Control Groups
2019
·
Paul Moser
·
Handbook of experimental pharmacology
·
56
PDF
Effects of mild traumatic brain injury on immunoreactivity for the inducible transcription factors c-Fos, c-Jun, JunB, and Krox-24 in cerebral regions associated with conditioned fear responding
1999
·
D.Nora Abrous
, Julio Rodriguez
, et al.
·
Brain Research
·
49
5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats
1999
·
Paul C Moser
, David J Sanger
·
European Journal of Pharmacology
·
46
Show more works
View as search
Works count:
95
Citation count:
4,870
H-index:
34
I10-index:
52
Year
Topic
Type